Atria Investments Inc Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Atria Investments Inc increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 14.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,724 shares of the company’s stock after acquiring an additional 736 shares during the quarter. Atria Investments Inc’s holdings in HCA Healthcare were worth $2,326,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Bangor Savings Bank boosted its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new stake in HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare in the second quarter valued at about $28,000. GPS Wealth Strategies Group LLC lifted its holdings in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new position in HCA Healthcare during the 2nd quarter valued at $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several recent research reports. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. TD Cowen lowered their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Barclays reduced their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research note on Friday, November 8th. Oppenheimer raised their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Finally, KeyCorp decreased their target price on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $385.00.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last ninety days. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

HCA opened at $345.36 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a 52 week low of $237.57 and a 52 week high of $417.14. The company has a fifty day moving average price of $387.05 and a two-hundred day moving average price of $357.11. The firm has a market capitalization of $87.48 billion, a PE ratio of 15.79, a P/E/G ratio of 1.35 and a beta of 1.68.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.76%. HCA Healthcare’s payout ratio is currently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.